Fluorescent Probe for Assessment of Renal Elimination
NCT: NCT07643467 · NOT_YET_RECRUITING
Brief Summary
Accurate measures of kidney function is important for precision dosing of many medications. The current methods of determining kidney function largely hinge on the use of equations that use common laboratory values such as serum creatinine \& static variables like age \& weight. These are helpful for trending over time, but often are inaccurate during times of medical illness. Other more accurate methods of measuring kidney function include urine collection, although this is not commonly used because of various reasons that make the collection inconvenient or unreliable. The new transdermal glomerular filtration (tGFR) device permits accurate, real-time evaluation of kidney function. This novel method has not been rigorously compared with urine collection \& other methods of determining kidney function in hospitalized patients. The goal of the study is to compare tGFR with other accepted methods of determining kidney function.
Frequently Asked Questions
What is Fluorescent Probe for Assessment of Renal Elimination?
Fluorescent Probe for Assessment of Renal Elimination is a clinical trial registered under NCT07643467. Current status: NOT_YET_RECRUITING.
What is the status of NCT07643467?
The current status of NCT07643467 (Fluorescent Probe for Assessment of Renal Elimination) is: NOT_YET_RECRUITING.
When did Fluorescent Probe for Assessment of Renal Elimination start?
Fluorescent Probe for Assessment of Renal Elimination started on 2026-07.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.